Get started
Author

Sara Alosaimy

Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study
2019 · Sarah C J Jorgensen, Evan J Zasowski, et al. · Clinical Infectious Diseases · 98
Evaluation of Eravacycline: A Novel Fluorocycline
2020 · Sara Alosaimy, Jacinda C. Abdul‐Mutakabbir, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 69
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
2021 · Sara Alosaimy, Abdalhamid M Lagnf, et al. · Open Forum Infectious Diseases · 59
PDF
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
2022 · Sara Alosaimy, Taylor Morrisette, et al. · Microbiology Spectrum · 56
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens
2020 · Jacinda C. Abdul‐Mutakabbir, Sara Alosaimy, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 56
Early Experience With Eravacycline for Complicated Infections
2020 · Sara Alosaimy, Kyle C Molina, et al. · Open Forum Infectious Diseases · 55
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections
2020 · Sara Alosaimy, Sarah C J Jorgensen, et al. · Open Forum Infectious Diseases · 54
PDF
Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
2021 · Taylor Morrisette, Sara Alosaimy, et al. · Open Forum Infectious Diseases · 52
Clinical pharmacy practice in Saudi Arabia: Historical evolution and future perspective
2020 · Hisham A. Badreldin, Sara Alosaimy, et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 52
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022
2023 · Ashlan J. Kunz Coyne, Sara Alosaimy, et al. · Microbiology Spectrum · 37
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
2023 · Amer El Ghali, Taylor Morrisette, et al. · Antimicrobial Agents and Chemotherapy · 36
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections
2021 · Nicholas Rebold, Taylor Morrisette, et al. · Open Forum Infectious Diseases · 32
PDF
Exploring anti-MRSA activity of chitosan-coated liposomal dicloxacillin
2018 · Aws Alshamsan, Fadilah Sfouq Aleanizy, et al. · Journal of Microbiological Methods · 32
Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis
2020 · Sara Alosaimy, Noor L. Sabagha, et al. · Infectious Diseases and Therapy · 31
PDF
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA—Salvaging the Gold Standards with Combination Therapy
2020 · Taylor Morrisette, Sara Alosaimy, et al. · Antibiotics · 30
PDF
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry
2023 · Sara Alosaimy, Michael J Rybak, et al. · The Lancet Infectious Diseases · 28
Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
2023 · Nicholas Rebold, Abdalhamid M. Lagnf, et al. · Microbiology Spectrum · 24
PDF
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens
2022 · Taylor Morrisette, Sara Alosaimy, et al. · Infectious Diseases and Therapy · 21
PDF
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study
2024 · Nicholas Rebold, Sara Alosaimy, et al. · Infectious Diseases and Therapy · 19
PDF
Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study
2019 · Mohammad Helmi, Sara AlOsaimy, et al. · BMC Oral Health · 19
PDF
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options
2021 · Nicholas Rebold, Dana Holger, et al. · Infectious Diseases and Therapy · 16
PDF
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam
2022 · Sara Alosaimy, Abdalhamid M Lagnf, et al. · Clinical Infectious Diseases · 15
Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting
2019 · Sara Alosaimy, Alka Vaidya, et al. · Drugs & Aging · 15
Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections
2022 · Dana J. Holger, Nicholas S. Rebold, et al. · Infectious Diseases and Therapy · 14
PDF
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
2020 · Taylor Morrisette, Abdalhamid M. Lagnf, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 14
Works count: 59
Citation count: 1,018
H-index: 19
I10-index: 28
Year
Topic
Type